News|Articles|October 3, 2026

Emerging Research Insights and New Advances in Neuroradiology

Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.

Will a new positron emission tomography (PET) agent be a game changer for glioma imaging? Are patients with diabetes and lower bone mineral density (BMD) on chest CT more susceptible to faster accumulation of white matter hyperintensity (WMH)? Can newly FDA-cleared software facilitate improved quality of amyloid PET imaging via structural MRI?

Related to this article

Radiology and Building the Alzheimer’s Care Pathway of the Future
Given the increasing prevalence of Alzheimer’s disease and a staggering number of people with dementia who are undiagnosed, this author discusses five essential keys for radiologists and their colleagues to facilitate earlier detection, precision care treatment and monitoring to help ensure timely care and intervention.